baber/WOPTO huggingface dataset:
Patent AU-2015284135-A1 (AU)
Title: Heteroaryl compounds useful as inhibitors of SUMO activating enzyme
Inventor: DUFFEY MATTHEW O
IPC: C07D239/24
Filed: 2015-06-30
Abstract: Disclosed are chemical entities which are compounds of formula (I); or pharmaceutically acceptable salts thereof; wherein Y, R
Patent AU-2015287046-A1 (AU)
Title: Magazine for storing bar-shaped workpieces for a machine tool
Inventor: GUSSMANN LUKAS
IPC: A47F7/00
Filed: 2015-06-10
Abstract: The invention relates to a magazine for storing bar-shaped workpieces. Said magazine (10) comprises at least one receiving member (12) that includes at least one pocket hole (15) for inserting an end portion (11a) of one bar-shaped workpiece (11) each. The end portion (11a) of a workpiece (11) accommodated in a pocket hole (15) is shorter, especially three to five times shorter, than the remaining portion of the workpiece (11) adjoining the end portion (11a) when viewed along the longitudinal axis (L) of the workpiece (11). The receiving member (12) is designed in such a way that the central axes (M) of the at least one pocket hole (15) define a first angle of inclination (β) along with the vertical line (V) in the operational position of the magazine (10). This feature has the effect of tilting the workpieces (11) in a defined tilting direction (K) and preventing same from hitting each other.
Patent AU-2015305566-A1 (AU)
Title: Self-contained anaerobic culture device for sulfate-reducing microorganisms
Inventor: BRUTINEL EVAN D
IPC: C12Q1/04
Filed: 2015-08-19
Abstract: The present disclosure provides a culture device for enumerating colonies of sulfate-reducing microorganisms. The device includes a body having a waterproof base, a waterproof coversheet attached to the base, and a growth compartment disposed therebetween. The growth compartment has a perimeter and an opening. A portion of the perimeter is defined by a waterproof seal. The portion can include >50% of the perimeter. Disposed in the growth compartment are a dry cold water-soluble gelling agent, a dry culture medium selected to facilitate growth of a sulfate-reducing bacterium or indicator reagent for detecting hydrogen sulfide production by a sulfate-reducing bacterium, and a dry first oxygen-scavenging reagent.
Patent AU-2015326677-A1 (AU)
Title: Chip card manufacturing method, and chip card obtained by said method
Inventor: EYMARD ERIC
IPC: G06K19/077
Filed: 2015-09-30
Abstract: The invention relates to a chip card manufacturing method. According to said method, the following are produced: a module comprising a substrate supporting contacts on one surface and conductive paths and a chip on the other; and an antenna (200) on a holder, the antenna comprising a contact pad (220) for respectively connecting to each of the ends thereof. A solder drop (230) is placed on each of the contact pads (220) of the antenna (200). The holder of the antenna (200) is then inserted between plastic layers. A cavity (400) is provided, in which the module can be accommodated and the solder drops (230) remain accessible. The height of the solder drops before heating is suitable for projecting into the cavity. A module is then placed in each cavity (400). The areas of the module that are located on the solder drops (230) are then heated such as to melt the solder and to solder the contact pads (220) of the antenna (200) to conductive paths of the module.
Patent AU-2015334651-A1 (AU)
Title: Device and method for mitigating seismic survey interference
Inventor: SALLAS JOHN JAMES
IPC: G01V1/00
Filed: 2015-10-20
Abstract: A computing system and method for mitigating, in a first seismic survey, cross- talk generated by a second seismic survey. The method includes performing (600) the first seismic survey with a first survey seismic source driven by a first survey pilot sweep, performing (602) the second seismic survey with a second survey seismic source, simultaneously with the first seismic survey, recording (604) with first survey seismic sensors (i) first survey seismic signals that originate from the first survey seismic source and (ii) second survey seismic signals that originate from the second survey seismic source, selecting (606) another first survey pilot sweep, which has less cross-correlation noise with the second survey seismic signals than the first survey pilot sweep, and continuing (608) the first seismic survey with the another first survey pilot sweep.
Patent AU-2015367322-A1 (AU)
Title: Device for the concentration of solar radiation
Inventor: STOGER ELMAR
IPC: F24S23/74
Filed: 2015-12-18
Abstract: The invention relates to a device (1) for the concentration of solar radiation in an absorber (1'), said device comprising an inflatable concentrator cushion (2) which has a cover film element (3'') with a light-permeable entry window (3) for coupling in solar radiation and a reflector film (6) for the concentration of solar radiation in an absorber (1'), the reflector film sub-dividing the concentrator cushion (2) into at least two hollow spaces (4, 5) and having a curvature in the inflated state of the concentrator cushion (2). The device also comprises a pivoting apparatus (7), with which the concentrator cushion (2) can be pivoted, in particular about its longitudinal axis, a retaining apparatus (31) secured to the pivoting apparatus (7), for retaining the concentrator cushion (2), and a setting device (56) for setting the curvature of the reflector film (6) of the concentrator cushion (2). The retaining apparatus (31) comprises a lower longitudinal support (33) which extends in the longitudinal direction of the concentrator cushion (2) and which is connected to a bottom film element (3') of the concentrator cushion (2). The setting device (56), for the purpose of setting the curvature of the reflector film (6), comprises a tensioning element (57) between the lower longitudinal support (33) of the retaining apparatus (31) and the reflector film (6), said tensioning element (57) being connected on one end to the reflector film (6) and on the other end to the lower longitudinal support (33) of the retaining apparatus (31).
Patent AU-2015374401-A1 (AU)
Title: Weight sensing base for an adjustable dumbbell system
Inventor: MORAN THOMAS H
IPC: G01G19/52
Filed: 2015-12-22
Abstract: In various implementations, an adjustable dumbbell system may include a handle assembly, two or more weight plates, and a base. The weight plates and the handle assembly may be configured such that each weight plate can be selectively coupled to and decoupled from the handle assembly. The base may be configured to support each of the weight plates. The base may include a sensing mechanism that senses a characteristic of the weight plates where the characteristic depends upon which of the weight plates are supported by the base.
Patent AU-2015399320-A1 (AU)
Title: Depressible keys and keyboards
Inventor: LOW KOK KIONG
IPC: G06F3/02
Filed: 2015-06-16
Abstract: According to various embodiments, a depressible key may be provided. The depressible key may include: a keytop; a scissors mechanism connected to the keytop; and a mechanical switch connected to the scissors mechanism.
Patent WO-2017035600-A1 (WO)
Title: Poussette pliable
Inventor: HUANG YING HUI
IPC: B62B7/06
Filed: 2016-09-02
Abstract: Cette invention concerne une poussette d'enfant pliable avec un cadre de poignée (30), un cadre de roue avant (10) et un cadre de roue arrière (20), reliés mutuellement au niveau d'une articulation à charnière (12, 22, 42) en vue d'un déplacement angulaire mutuel entre des configurations pliée et dépliée. L'articulation à charnière présente deux axes d'articulation parallèles espacés, autour desquels les cadres (10, 20, 30) tournent l'un par rapport à l'autre. La poussette est en outre pourvue d'un élément de blocage (43, 44) mobile entre une position bloquée dans laquelle les cadres (10, 20, 30) sont bloqués dans la configuration dépliée, et une position débloquée, permettant aux cadres (10, 20, 30) de pivoter vers la configuration pliée. L'élément de blocage (43, 44) se déplace dans une direction transversale aux axes d'articulation parallèles de sorte à mieux transférer les charges entre les cadres.
Patent AU-2016201371-A1 (AU)
Title: Systems and associated methods for producing a 3d sonar image
Inventor: PROCTOR ALAN LEE
IPC: G01S15/89
Filed: 2016-03-02
Abstract: Provided are a sonar system and transducer assembly for producing a 3D image of an underwater environment. The sonar system may include a housing mountable to a watercraft having a transmit transducer that may transmit sonar pulses into the water. 5 The system may include at least one sidescan transducer array in the housing that receives first and second sonar returns with first and second transducer elements and converts the first and second returns into first and second sonar return data. A sonar signal processor may then generate a 3D mesh data using the first and second sonar return data and at least a predetermined distance between the transducer elements. An 10 associated method of using the sonar system is also provided. 36-, TRANSDUCER 72, TRANSCEIVER STORAGE SONAR SIGNAL MODULE PROCESSOR COMMUNICATIONS DISPLAY INTERFACE
Patent AU-2016203284-A1 (AU)
Title: Blind decoding for an enhanced physical downlink control channel (epdcch)
Inventor: CHEN XIAOGANG
IPC: H04J11/00
Filed: 2016-05-20
Abstract: Technology for blind decoding downlink control information (DCI) from an enhanced physical downlink control channel (EPDCCH) is disclosed. In an example, a user equipment (UE) can 5 include a processor configured to: Recursively attempt to decode the DCI from enhanced control channel elements (ECCE) of the EPDCCH from physical resource block (PRB) region candidates in a PRB set using a selected set of enhanced resource element group (EREG) index maps for the ECCE until the DCI is successfully decoded; and decode the DCI with an EREG index map associated with a same aggregation level used to encode the DCI. Each EREG index 0 map can be configured for a different aggregation level (AL).
Patent AU-2016208270-A1 (AU)
Title: Peptides for use in the treatment of IL-1 related diseases and conditions
Inventor: PASPALIARIS VASILIS
IPC: A61K38/10
Filed: 2016-07-25
Abstract: The present invention relates to a peptide, more particularly to a peptide comprising D-amino 5 acids, and compositions containing the peptide, which are suitable for the treatment of IL-1 related diseases and conditions. 8000072_1 (GHMatters) P86872.AU.2 25/07/16
Patent AU-2016209420-A1 (AU)
Title: Levodopa and carbidopa intestinal gel and methods of use
Inventor: CONJEEVARAM RAJKUMAR
IPC: A61K47/38
Filed: 2016-01-20
Abstract: The present disclosure relates to (a) an improved pharmaceutical composition comprising a levodopa active agent and a carbidopa active agent (b) methods of producing the pharmaceutical composition and (c) methods of treating Parkinson's disease and associated conditions comprising administering the pharmaceutical composition to a subject with Parkinson's disease.
Patent AU-2016229086-A1 (AU)
Title: Solid dispersions
Inventor: CHEN ZHENGMING
IPC: A01N57/00
Filed: 2016-03-10
Abstract: An ospemifene solid dispersion for enhancing solubility and bioavailability,, and methods of preparation thereof are disclosed. The solid dispersion comprises an active pharmaceutical ingredient, such as ospemifene, and a hydfophilie carrier, such as copovidone, hypromellose acetate succinate, polyvinylpyrrolidine, a polyvinylpyrrolidine/vinyl acetate co-polymer, hydroxy! propyl methylcellulose, hypromellose acetate succinate, a Eudragit® compound, hydroxypropylcellulose, a polyvinyl caprolactam-polyvinyl acetate polyethylene glycol graft co-polymer, hydroxypropyl methylcellulose phthalate, and mixtures thereof, and optionally a surfactant The ospemifene solid, dispersions can be used in methods of treating a symptom related, to menopause, such as vaginal dryness or sexual dysfunction, or in methods of treating osteoporosis.
Patent AU-2016258533-A1 (AU)
Title: Determining source of side-loaded software
Inventor: RICHARDSON DAVID
IPC: G06F21/50
Filed: 2016-04-18
Abstract: A source of side-loaded software is determined. An action may be performed in response to the determination of the source. In one case, the handling of an application on a mobile device may be based on whether the source of the application is trusted or untrusted. If a software application being newly-installed on a mobile device of a user is determined to be untrusted, installation or execution is blocked. In one approach, the determination of the source includes: determining whether a first source identifier of a first application matches a white list of source identifiers or a black list of source identifiers; and sending the first source identifier and a first application identifier for the first application to a different computing device.
Patent AU-2016259746-A1 (AU)
Title: Process control system for regulating and controlling a modular plant for manufacturing biopharmaceutical and biological macromolecular products
Inventor: SCHWAN PETER
IPC: C07K1/36
Filed: 2016-05-10
Abstract: The invention relates to a modular production plant for continuously manufacturing and/or processing biopharmaceutical products and to a computer-implemented method for controlling processes in the modular plant for manufacturing biopharmaceutical and biological macromolecular products, in particular proteins, e.g. monoclonal antibodies, vaccines, nucleic acids such as DNA, RNA and plasmids as well as the derivatives thereof in a controlled manner.
Patent AU-2016260303-A1 (AU)
Title: Modular activity board
Inventor: KRAMER EITAN
IPC: A63B22/16
Filed: 2016-05-12
Abstract: An apparatus for receiving one or more activity attachments including a deck having one or more openings along a long axis of the deck and between the top surface and the bottom surface of the deck. Each of the one or more openings having a circular aperture for receiving an accessory of a set of accessories. Each accessory of the set of accessories providing an activity for a user of the activity. Each accessory having an attachment platform configured to attach the accessory to the board. The attachment platform having a locking mechanism to engaging with a complementary locking mechanism of the board.
Patent AU-2016263176-A1 (AU)
Title: Pharmaceutical combination of everolimus with dactolisib
Inventor: GLASS DAVID
IPC: A61P25/00
Filed: 2016-05-20
Abstract: The present invention relates to a combination comprising (a) RAD001, or a pharmaceutically acceptable salt thereof, and (b) BEZ235, or pharmaceutically acceptable salt thereof, for simultaneous, separate or sequential use for enhancement of an immune response; a pharmaceutical composition comprising such combination; a method of enhancing immune response in a subject comprising administration of said combination to a subject in need thereof; use of such combination for preparation of a medicament for the enhancement of an immune response; and a commercial package thereto.
Patent AU-2016285868-A1 (AU)
Title: Compositions and methods related to scavanger particles
Inventor: HAWTHORNE LOUIS
IPC: A61K39/395
Filed: 2016-06-29
Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
Patent AU-2016302144-A1 (AU)
Title: Heterocyclic compounds useful as modulators of TNF alpha
Inventor: XIAO HAI-YUN
IPC: C07D401/14
Filed: 2016-08-02
Abstract: Disclosed are compounds of Formula (I) or a salt thereof, wherein: A is CR
Patent AU-2016308365-A1 (AU)
Title: Anti-DLL3 antibody drug conjugates and methods of use
Inventor: DYLLA SCOTT J
IPC: C07K16/28
Filed: 2016-08-19
Abstract: Provided are novel anti-DLL3 antibodies and antibody drug conjugates, and methods of using such anti-DLL3 antibodies and antibody drug conjugates to treat cancer.
Patent AU-2016315947-A1 (AU)
Title: Wireless patient monitoring systems and methods
Inventor: AL-ALI AMMAR
IPC: A61B5/00
Filed: 2016-08-31
Abstract: A patient monitoring system to help manage a patient that is at risk of forming one or more pressure ulcers is disclosed. The system includes a patient-worn wireless sensor that senses the patient's orientation and wirelessly transmits information indicative of the sensed orientation to a patient monitor. The patient monitor receives, stores, and processes the transmitted information. It also displays and transmits information indicative of the patient's orientation to help caregivers manage the patient's risk of formation of one or more pressure ulcers. The system can identify the present orientation of the patient and determine how long the patient has been in the present orientation. If the patient remains in an orientation beyond a predefined duration, the system can notify the patient and/or caretakers that the patient is due to be repositioned.
Patent AU-2016325991-A1 (AU)
Title: Quantum dot security inks
Inventor: MCDANIEL HUNTER
IPC: G01N21/64
Filed: 2016-06-12
Abstract: A security ink is provided which includes a liquid medium having a plurality of quantum dots disposed therein. Upon excitation with a suitable light source, the ink exhibits a quantum yield greater than 30%, and a photoluminescence which has a lifetime of more than 40 nanoseconds and which varies by at least 5% across the emission spectrum of the quantum dots. Also disclosed are apparatuses for using the same for anti-counterfeit or authentication purposes, which uniquely identifying the presence of photoluminescent materials by spectrally resolving their photoluminescence lifetime.
Patent AU-2016353153-A1 (AU)
Title: Glycan-interacting compounds and methods of use
Inventor: EAVARONE DAVID A
IPC: C07K16/30
Filed: 2016-11-10
Abstract: The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include humanized antibodies, derivatives and fragments thereof as well as related compositions and kits. Methods of using glycan-interacting antibodies for treatment and diagnosis are included.
Patent AU-2016358147-A1 (AU)
Title: Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives
Inventor: XU SHENG
IPC: C07C209/60
Filed: 2016-11-14
Abstract: A process for the synthesis of the intermediate useful for the preparation of 1,3,4- triazines, are disclosed.
Patent AU-2016383072-A1 (AU)
Title: Intelligent wireless communications for continuous analyte monitoring
Inventor: BURNETTE DOUGLAS WILLIAM
IPC: G01N27/416
Filed: 2016-12-20
Abstract: Various embodiments relate generally to continuous monitoring of analyte values received from an analyte sensor system. In some example embodiments, there is provided a method that includes receiving sensor information, calculating and storing estimated analyte measurement values based upon the received sensor information. The method also includes determining one or more communication conditions, and instructing a transceiver to advertise to a first display device in accordance with one or more communication variables based upon the one or more communication conditions. The method then transmits the estimated analyte measurement values to the at least first display device. Related systems, methods, and articles of manufacture are also described.
Patent AU-2016429122-A1 (AU)
Title: Terminal device scheduling method, network device, and terminal device
Inventor: TANG HAI
IPC: H04W72/04
Filed: 2016-11-11
Abstract: Embodiments of the present invention provide a terminal device scheduling method, a network device, and a terminal device. The method comprises: a network device determines first configuration information, the first configuration information being used for instructing a terminal device to perform execution to pre-schedule a time-domain resource and a frequency-domain resource used by a service; and the network device sends the first configuration information to the terminal device. By means of the terminal device scheduling method provided in the embodiment of the present invention, the terminal device can be more flexibly scheduled.
Patent WO-2019033139-A1 (WO)
Title: "manufacture of hyperpolarised agents"
Inventor: BROADWAY DAVID
IPC: G01R33/28
Filed: 2017-08-17
Abstract: This disclosure provides a method for hyperpolarizing an agent. The agent is located in close proximity to a quantum probe that is in a first energy state and a magnetic field is applied to the quantum probe and the agent. Quantum control radiation applied to the probe brings the quantum probe to a second energy state to allow cross-relaxation between the quantum probe and the agent while the magnetic field is applied. The magnetic field is of a magnetic field strength that adjusts the energy states of the quantum probe to bring a probe spin transistion of the quantum probe into resonance with an agent spin transition of the agent to allow transfer of energy and thereby activate the cross -relaxation between the quantum probe and the agent to polarise the agent. This allows for polarisation under room temperature with relatively weak magnetic fields.
Patent WO-2018094474-A1 (WO)
Inventor: BILBE DREW BENJAMIN
IPC: A23L2/60
Filed: 2017-11-28
Abstract: Provided herein are natural sweetener combinations for use in the manufacture of ingestible products, typically foods and beverages, wherein the natural sweetener combinations comprise or consist of two or more of a stevia extract, a sugar alcohol and monk fruit extract. Also provided are ingestible products, typically foods and beverages, containing said natural sweetener combinations.
Patent AU-2017203608-A1 (AU)
Title: Mobile human challenge-response test
Inventor: KALGI AVINASH
IPC: H04L9/32
Filed: 2017-05-30
Abstract: MOBILE HUMAN CHALLENGE-RESPONSE TEST A method comprises sending (252), by a user device to a computing device, a request including a device identifier (ID) identifying the user device; receiving (254), from the computing device, a request ID and a human challenge-response test, the request ID being at least one of an application ID or a one-time key generated by the computing device; receiving, from a user interface of the user device, a user's solution to the human challenge-response test; and sending (258), to the computing device, the request ID and a response hash value generated on the user's solution, and at least one of the device ID or the request ID. The method also comprises receiving (260), from the computing device, a verification result indicating whether the request is permitted, wherein the verification result is based on at least whether the response hash value is received by the computing device within a variable expiration time period, the variable expiration time period being set based on at least information received in the request.